Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 26, 2014
In vitro-in vivo evaluation of lipid based formulations of the CETP inhibitors CP-529,414 (torcetrapib) and CP-532,623Claire L McEvoy, Natalie L Trevaskis, Glenn A Edwards, et al.
Neurology|June 11, 2003
Longitudinal outcome of Parkinson's disease patients with psychosisS A Factor, P J Feustel, J H Friedman, et al.
Biological Psychiatry|April 21, 1998
Psychobiological heterogeneity of familial and sporadic schizophreniaD Malaspina, J H Friedman, C Kaufmann, et al.
The American Journal of Psychiatry|June 1, 2000
Relation of familial schizophrenia to negative symptoms but not to the deficit syndromeD Malaspina, R R Goetz, S Yale, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 1998
Clozapine use in Parkinson's disease: a retrospective analysis of a large multicentered clinical experienceR M Trosch, J H Friedman, M C Lannon, et al.
The American Journal of Psychiatry|March 7, 2001
Traumatic brain injury and schizophrenia in members of schizophrenia and bipolar disorder pedigreesD Malaspina, R R Goetz, J H Friedman, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 2, 2014
Identification of a novel, non-tetrahydroquinoline variant of the cholesteryl ester transfer protein (CETP) inhibitor torcetrapib, with improved aqueous solubilityAmit S Kalgutkar, Kosea S Frederick, Heather L Hatch, et al.
American Journal of Medical Genetics|December 3, 1999
Suggestive linkage of chromosome 10p to schizophrenia is not due to transmission ratio distortionS V Faraone, J Meyer, T Matise, et al.
Pageof 10